Aurorix en es it fr

Aurorix Brand names, Aurorix Analogs

Aurorix Brand Names Mixture

  • No information avaliable

Aurorix Chemical_Formula

C13H17ClN2O2

Aurorix RX_link

No information avaliable

Aurorix fda sheet

Aurorix msds (material safety sheet)

Aurorix Synthesis Reference

No information avaliable

Aurorix Molecular Weight

268.739 g/mol

Aurorix Melting Point

No information avaliable

Aurorix H2O Solubility

No information avaliable

Aurorix State

Solid

Aurorix LogP

1.298

Aurorix Dosage Forms

Tablet

Aurorix Indication

For the treatment of depression.

Aurorix Pharmacology

Moclobemide belongs to a class of MAOI antidepressants known as reversible inhibitors of monoamine oxidase type-A (RIMAs). The primary role of monoamine oxidase MAO lies in the metabolism of and regulation of the levels of monoamines (serotonin, norepinephrine, and dopamine). Within neurons, MAO appears to regulate the levels of monoamines released upon synaptic firing. Since depression is associated with low levels of monoamines, the inhibition of MAO serves to ease depressive symptoms. RIMAs demonstrate transient inhibition of the substrate binding site of MAO-A as well as competitive displacement from this site by bioamines. The RIMAs are distinguished from the older monoamine oxidase inhibitors (MAOIs) by their selectivity and reversibility.

Aurorix Absorption

No information avaliable

Aurorix side effects and Toxicity

No information avaliable

Aurorix Patient Information

No information avaliable

Aurorix Organisms Affected

Humans and other mammals